Torsten Vahl, M.D., director of experimental and translational research, Structural Heart and Valve Center and at the ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug ...
October 9, 2019 — Medtronic is recalling the 6 French Sherpa NX Active Guide Catheter due to a risk of the outer ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
October 8, 2019 — PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) ...
American Heart Association President Robert Harrington, M.D., interventional cardiologist and the Arthur L. Bloomfield ...
William O’Neill, M.D., medical director of the Center for Structural Heart Disease at Henry Ford Hospital, Detroit ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Henry Ford Hospital in Detroit gets a lot of referrals for very sick patients seeking a last resort treatment in its ...
Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from the 2019 Transcatheter ...
October 4, 2019 – A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-year ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...
October 4, 2019 – RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced ...
October 3, 2019 – Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and ...
During cardiology fellowship, my institution had a hand manifold system. I found it difficult to use at times, and it ...
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...
October 3, 2019 – The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...
Interview with John Carroll, M.D., director of interventional cardiology, Robert Quaife, M.D., director of advanced ...